Physicians use social media to identify cutaneous leishmaniasis in teen travelers

A new report details how physicians and patients used social media to help diagnose cutaneous leishmaniasis in a group of teens who traveled on a youth adventure trip to Israel. Their posts quickly brought the cluster to the attention of the teens and their parents, leading to prompt recognition of the cause of their skin lesions and appropriate treatment.

People with cutaneous leishmaniasis develop skin sores after being infecting with Leishmania parasites, which are spread by the bite of sand flies..

"Our findings highlight the growing role of social media in medicine for facilitating communication and crowd sourcing a diagnosis for patients," said Dr. Kanokporn Mongkolrattanothai, lead author of the Pediatric Dermatology report.

http://www.news-medical.net/news/20160802/Physicians-use-social-media-to-identify-cutaneous-leishmaniasis-in-teen-travelers.aspx

Featured Posts
Recent Posts
Archive
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

 Impavido® (miltefosine) is an FDA-approved treatment for cutaneous,  mucosal and visceral leishmaniasis in patients 12 years of age and older. PLEASE SEE FULL PRESCRIBING INFO 

®

Contact Your Doctor or the CDC to Learn More about IMPAVIDO (miltefosine)

Impavido is a registered trademark of Knight Therapeutics Licensed exclusively to Profounda in the USA

© 2015 Profounda, Inc. 

For Emergencies
Call 911